KROS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Keros Therapeutics (KROS) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

KROS is expected to report earnings to fall 3.55% to -136 cents per share on February 27

Keros Therapeutics KROS Stock Earnings Reports

Q4'24

Est.

$-1.36

Q3'24

Missed

by $0.13

Q2'24

Beat

by $0.01

Q1'24

Beat

by $0.12

Q4'23

Beat

by $0.03

The last earnings report on November 06 showed earnings per share of -140 cents, missing the estimate of -127 cents. With 419.34K shares outstanding, the current market capitalization sits at 729.13M.

View a ticker or compare two or three

Compare

KROS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For KROS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for KROS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on treatments for rare muscle diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1050 Waltham Street

Phone

+1 617 314-6297

Employees

136

Web

https://www.kerostx.com